Resources
Predicting outcomes in esophageal adenocarcinoma following neoadjuvant chemoradiation: Interactions between tumor response and survival
J Thorac Cardiovasc Surg, Vol. S0022-5223, Issue 23, Pages 01091-01097, 2023
PMID: 37967764
The prognostic value of tumor regression scores (TRS) in patients with esophageal adenocarcinoma (EAC) who underwent neoadjuvant chemoradiation remains unclear. We sought to investigate the prognostic value of pathologic and metabolic treatment response among EAC patients undergoing neoadjuvant chemoradiation.
Considering Genomic Research?
Company
Resources
Research
- Tumor Microenvironment Solutions
- Immune Profiling Services
- NGS Services
- BioFX Bioinformatics Services
- Antibody Discovery Services
Diagnostics
Contact
2025 © MedGenome • All Rights Reserved